Julia Rasor, Medical Device Strategist at Rasor Consulting Group, is a strategic entrepreneur with an extensive track record of leading very successful solutions for business, clinical, or regulatory roadblocks as well as technical hurdles. She uses a combination of science, business, and regulatory savvy and tools developed from a 50-company experience to 'Fast Track' companies reducing cost and risk thus seizing the competitive advantage.
Julia is inventor of a $100M/year revenue medical product (the first commercial ultrasonic contrast agent; CEO Founder of a drug delivery company that closed ~$38M to date and whose present CEO is the former CEO of Alza and Glaxo; Member of 5 Scientific Advisory Boards; Inventor of 13 issued and pending patents; Founder of Rasor Consulting Group celebrating 25 years of success for clients at http://www.MedicalDevice.com ; author of 'Rasor Resource Newsletter', a periodical publication that provides valuable, proven tools for medical device executives (subscription and archive available on website); and author of 30 publications and 20 White Papers yielding multi-million dollar venture funding, increased sales, and reversal of FDA’s previously stated decisions [Rasor JS. Producing a white paper: A parallel path making clinical data available before publication. Amer Med Writers H. 1991 Dec;6(4):12]. She often works as an interim Chief Strategy Officer (CSO).
Julia holds an M.S. in Human Physiology from the University of California, Davis, a B.S. in Biology from Wright State University in Dayton, Ohio, a Professional Certificate in Engineering Management from University of California in San Diego (a 2-year post baccalaureate academic study in management science), and a Multidisciplinary Medical Communications Certificate from the American Medical Writers Association (AMWA, Founded in 1940).
